Strong Buy
Buy
Hold
Sell
Strong Sell
Consensus
| Date | Grading Company | New Grade | Previous Grade | Action | Price When Posted | News Title | Publisher |
|---|---|---|---|---|---|---|---|
| 2025-08-15 | H.C. Wainwright | Buy | Buy | Hold | $4.98 | BioXcel Therapeutics price target raised to $10 from $8 at … | TheFly |
| 2025-06-23 | H.C. Wainwright | Buy | Buy | Hold | $1.65 | BioXcel Therapeutics target adjusted to $8 from $3 at H.C. … | TheFly |
| 2024-10-21 | H.C. Wainwright | Buy | Buy | Hold | $0.5659 | BioXcel Therapeutics (BTAI) PT Lowered to $5 at H.C. Wainwr… | StreetInsider |
| 2024-09-06 | H.C. Wainwright | Buy | Buy | Hold | $0.5901 | H.C. Wainwright Reiterates Buy Rating on BioXcel Therapeuti… | StreetInsider |
| 2024-04-15 | H.C. Wainwright | Buy | Buy | Hold | $2.9 | BioXcel Therapeutics (BTAI) PT Lowered to $10 at H.C. Wainw… | StreetInsider |
| 2023-08-15 | Wells Fargo | Buy | Buy | Hold | $4.33 | NVIDIA To Rally More Than 23%? Here Are 10 Other Analyst Fo… | Benzinga |
| 2023-05-26 | Goldman Sachs | Neutral | Neutral | Hold | $N/A | Goldman Sachs Maintains Neutral Rating for BioXcel Therapeu… | Benzinga |
| 2023-03-21 | Piper Sandler | Buy | Buy | Hold | $19.79 | Meta Platforms To Rally Over 26%? Here Are 10 Other Analyst… | Benzinga |
| 2023-03-10 | Oppenheimer | Outperform | N/A | Initialise | $20.68 | Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2… | Benzinga |
| 2023-03-10 | JonesTrading | Buy | N/A | Initialise | $20.68 | Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2… | Benzinga |